Immunic Inc. Stock
Price
Target price
€0.67
€0.67
5.390%
0.033
5.390%
€8.76
14.11.25 / Tradegate
WKN: A2PHD4 / Symbol: IMUX / Name: Immunic / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Immunic Inc. Stock
A very strong showing by Immunic Inc. today, with an increase of €0.033 (5.390%) compared to yesterday's price.
The stock is one of the favorites of our community with 24 Buy predictions and 1 Sell predictions.
Based on the current price of 0.67 € the target price of 8 € shows a potential of 1088.71% for Immunic Inc. which would more than double the current price.
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Immunic Inc. stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Immunic Inc. in the next few years
Pros
?
G***** c******* t* c**********
?
C******** o* t** e**********
?
M***** P*******
Cons
?
B****
?
W********* I********* f** t** n*** y****
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Immunic Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Immunic Inc. | 5.390% | 8.199% | -7.555% | -34.724% | -33.432% | -52.871% | -95.794% |
| NanoViricides Inc. | -2.360% | -29.814% | 0.893% | -8.130% | -24.667% | -31.034% | -61.824% |
| Actinium Pharmaceuticals Inc. | 4.320% | 0.731% | -16.956% | -29.943% | -4.257% | -90.923% | -89.196% |
| Ocuphire Pharma Inc. | 5.080% | -8.555% | -7.809% | 43.297% | 42.523% | -39.037% | - |
Comments
Immunic (NASDAQ:IMUX) had its price target lowered by analysts at HC Wainwright from $10.00 to $8.00. They now have a "buy" rating on the stock.
Show more
Ratings data for IMUX provided by MarketBeat
Immunic (NASDAQ:IMUX) had its price target lowered by analysts at D. Boral Capital from $10.00 to $8.00. They now have a "buy" rating on the stock.
Show more
Ratings data for IMUX provided by MarketBeat
Immunic (NASDAQ:IMUX) is now covered by analysts at Roth Capital. They set a "buy" rating and a $3.00 price target on the stock.
Show more
Ratings data for IMUX provided by MarketBeat
News
EQS-News: Immunic, Inc. Reports Third Quarter 2025 Financial Results and Provides Corporate Update
EQS-News: Immunic, Inc. Reports Third Quarter 2025 Financial Results and Provides Corporate Update
EQS-News: Immunic to Participate in Industry and Investor Conferences in November
EQS-News: Immunic to Participate in Industry and Investor Conferences in November
EQS-News: Immunic to Participate in Scientific and Investor Conferences in October
EQS-News: Immunic to Participate in Scientific and Investor Conferences in October